DDX1 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

19 results for “DDX1”

Trials

Not yet recruiting

DDX17 Orchestrate Septic Vascular Endothelial Pyroptosis by Controlling Gasdermin D Pore Formation

60 participants · First posted Aug 28, 2023

Study of Families With an Hemopathies Predisposition Related to the DDX41 Gene.

910 participants · First posted Sep 1, 2023

A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH

67 participants · First posted May 13, 2024

Drugs

DD1

PAT-DX1

GR-DD1

News

MD Anderson Study Uncovers R-Loop Export as Driver of Inflammaging, Points to FDA-Approved Selinexor as Potential Treatment

D&D Pharmatech Raises $165M as MASH Drug DD01 Approaches Key Phase 2 Readout

D&D Pharmatech Completes Enrollment for Phase 2 MASH Trial of Novel Dual GLP-1/Glucagon Agonist DD01

Page 1 of 2